Close

STANDARDS FOR PRIVACY OF INDIVIDUALLY IDENTIFIABLE HEALTH INFORMATION UNDER THE HEALTH INSURANCE PORTABILITY AND ACCOUNTABILITY ACT

The Biotechnology Industry Organization ("BIO") is pleased to have the opportunity to submit testimony expressing our concerns about the federal medical privacy regulation issued under...

BIO 2001 “Partnering For Life” Preliminary Program Available

Reporters urged to register now!

WASHINGTON, D.C. (March 13, 2001) – The Biotechnology Industry Organization (BIO) today announced that the preliminary program for the BIO 2001...

BIO REAFFIRMS SUPPORT OF EPA DECISION TO END “SPLIT” BIOTECH CROP APPROVALS

WASHINGTON, D.C. (March 7, 2001) -- The Biotechnology Industry Organization (BIO) today issued the following statement following the Environmental Protection Agency’s (EPA) announcement that it...

TAX CUTS WOULD BOOST MEDICAL INNOVATIONS

Washington, D.C. (March 6, 2001) -- The Biotechnology Industry Organization (BIO) today issued the following statement following Senate introduction of a bill that would reduce taxes on profits...

Biotech Ads Seek Ears Of President Bush, D.C. Policymakers

Washington, D.C. (March 1, 2001) -- The Biotechnology Industry Organization (BIO) will begin a six month television advertising campaign this weekend on both national and cable networks. The ads...

BIO Statement Regarding Nobel Laureates’ Support for Stem Cell Research

WASHINGTON, DC (February 22, 2001) --Michael J. Werner, director of federal government relations and bioethics counsel for the Biotechnology Industry Organization (BIO) today issued the following...

Biotech Medicines on the Market Top 110 With Hundreds More in the Pipeline

Washington, D.C. – A record 32 biotechnology drugs, vaccines and new indications for existing medicines were approved by the U.S. Food and Drug Administration (FDA) in 2000.

Of the 32 FDA...

BIO Welcomes Opening Of New Bipartisan Discussions On Drug Coverage For Medicare Beneficiaries

WASHINGTON, D.C. (February 15, 2001) -- Carl B. Feldbaum,president of the Biotechnology Industry Organization (BIO), issued the following statement today on the opening of bipartisan discussions in...

US Sen. Tim Hutchinson, Newt Gingrich To Participate In BIO’s CEO & Investor Conference

WASHINGTON, D.C. (February 14, 2001) – U.S. Sen. Tim Hutchinson (R-Arkansas) and Newt Gingrich, former Speaker of the U.S. House of Representatives, will be featured with Carl B. Feldbaum,...

Publication Of Human Genome Sequence Launches New Era In Medicine

WASHINGTON, D.C. (February 12, 2001) - Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), issued the following statement on announcements today that Science and Nature...